Phase I/Phase II Applications
Significance:
- Does
the proposed project have commercial potential to lead to a marketable
product or process?
- Does
this study address an important problem?
- What may be the anticipated commercial and societal benefits of the
proposed activity?
- If
the aims of the application are achieved, how will scientific knowledge
be advanced?
- Does
the application lead to enabling technologies (e.g., instrumentation,
software) for further discoveries?
- Will
the technology have a competitive advantage over existing/alternate
technologies that can meet the market needs?
Approach:
- Are
the conceptual framework, design, methods, and analyses adequately developed,
well integrated, and appropriate to the aims of the project?
- Is
the proposed plan a sound approach for establishing technical and commercial
feasibility?
- Does
the applicant acknowledge potential problem areas and consider alternative
strategies?
- Are
the milestones and evaluation procedures appropriate?
Innovation:
- Does
the project challenge existing paradigms or employ novel technologies,
approaches or methodologies?
- Are
the aims original and innovative?
Investigators:
- Is
the Principal Investigator capable of coordinating and managing the
proposed SBIR/STTR?
- Is
the work proposed appropriate to the experience level of the Principal
Investigator and other researchers, including consultants and subcontractors
(if any)?
- Are
the relationships of the key personnel to the small business and to
other institutions appropriate for the work proposed?
Environment:
- Is
there sufficient access to resources (e.g., equipment, facilities)?
- Does
the scientific and technological environment in which the work will
be done contribute to the probability of success?
- Do
the proposed experiments take advantage of unique features of the scientific
environment or employ useful collaborative arrangements?
Additional Review Criteria
In addition to the above criteria, your application will also be reviewed
with respect to the following:
Projections:
The adequacy of the proposed protection for humans, animals, or the
environment, to the extent they may be adversely affected by the project
proposed in the application.
Inclusion:
The adequacy of plans to include subjects from both genders, all racial
and ethnic groups (and subgroups), and children as appropriate for the
scientific goals of the research. Plans for the recruitment and retention
of subjects will also be evaluated. (See Inclusion Criteria included
in the section on Federal Citations, below)
Budget:
The reasonableness of the proposed budget and the requested period of
support in relation to the proposed research.
Phase II Applications
In addition to the above criteria:
- How
well did the applicant demonstrate progress toward meeting the Phase
I objectives, demonstrating feasibility, and providing a solid foundation
for the proposed Phase II activity?
- Did
the applicant submit a concise Product Development Plan that adequately
addresses the four areas described in the Research Plan item J?
- Does
the project carry a high degree of commercial potential, as described
in the Product Development Plan?
Phase I/Phase II/Fast-Track Application Review Criteria
For Phase I/Phase II Fast Track applications, the following criteria
also will be applied:
- Does
the Phase I application specify clear, appropriate, measurable goals
(milestones) that should be achieved prior to initiating Phase II?
- Did
the applicant submit a concise Product Development Plan that adequately
addresses the four areas described in the Research Plan, item J?
- To
what extent was the applicant able to obtain letters of interest, additional
funding commitments, and/or resources from the private sector or non-SBIR/
STTR funding sources that would enhance the likelihood for commercialization?
- Does
the project carry a high degree of commercial potential, as described
in the Product Development Plan?
- Phase
I and Phase II Fast-Track applications that satisfy all of the review
criteria will receive a single rating. Failure to provide clear, measurable
goals may be sufficient reason for the scientific review group to exclude
the Phase II application from Fast-Track review.
|